GeoVax Labs, Inc.
NASDAQ Capital MarketTotal Valuation
GeoVax Labs, Inc. carries a market capitalization of 88,758.00, placing it among publicly traded companies globally. Its enterprise value stands at -877,191.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 88,758.00 |
| Enterprise Value | -877,191.00 |
Share Statistics
GeoVax Labs, Inc. currently has 2.82M shares outstanding.
| Shares Outstanding | 2.82M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
GeoVax Labs, Inc. maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.06 |
| Quick Ratio | 0.55 |
| Debt / Equity | 79.91 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -309.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
GeoVax Labs, Inc.'s stock has declined approximately -96.875% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.875% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.06 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -21.44M, while operating income came in at -21.51M.
| Revenue | 852,282.00 |
| Gross Profit | N/A |
| Operating Income | -21.51M |
| Pretax Income | -21.37M |
| Net Income | -21.37M |
| EBITDA | -21.44M |
| EBIT | -21.51M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
GeoVax Labs, Inc. holds 1.27M in cash and equivalents against 394,571.00 in total debt, resulting in a net debt position of -1.27M. Total book value stands at -156.08M, with working capital of 139,783.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.27M |
| Total Debt | 394,571.00 |
| Net Debt | -1.27M |
| Equity (Book Value) | -156.08M |
| Book Value Per Share | N/A |
| Working Capital | 139,783.00 |
Cash Flow
GeoVax Labs, Inc. produced -19.05M in operating cash flow over the past twelve months.
| Operating Cash Flow | -19.05M |
| Capital Expenditures | -10,718.00 |
| Free Cash Flow | -19.06M |
| FCF Per Share | N/A |
Margins
GeoVax Labs, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -2,523.43 and net profit margin of -2,507.27 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -2,523.43 |
| Pretax Margin | -2,507.27 |
| Profit Margin | -2,507.27 |
| EBITDA Margin | -2,515.93 |
Scores
GeoVax Labs, Inc. posts an Altman Z-Score of -98.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -98.37 |